Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Different pathologies but equal levels of responsiveness to the recombinant F1 and V antigen vaccine and ciprofloxacin in a murine model of plague caused by small- and large-particle aerosols.

Thomas RJ, Webber D, Collinge A, Stagg AJ, Bailey SC, Nunez A, Gates A, Jayasekera PN, Taylor RR, Eley S, Titball RW.

Infect Immun. 2009 Apr;77(4):1315-23. doi: 10.1128/IAI.01473-08. Epub 2009 Feb 2.

2.

Protecting against plague: towards a next-generation vaccine.

Williamson ED, Oyston PC.

Clin Exp Immunol. 2013 Apr;172(1):1-8. doi: 10.1111/cei.12044. Review.

3.

Prospects for new plague vaccines.

Feodorova VA, Corbel MJ.

Expert Rev Vaccines. 2009 Dec;8(12):1721-38. doi: 10.1586/erv.09.129. Review. Erratum in: Expert Rev Vaccines. 2010 Jan;9(1):110.

PMID:
19943765
4.

Plague vaccines and the molecular basis of immunity against Yersinia pestis.

Quenee LE, Schneewind O.

Hum Vaccin. 2009 Dec;5(12):817-23. Epub 2009 Dec 1. Review.

PMID:
19786842
5.

Prevention of bubonic and pneumonic plague using plant-derived vaccines.

Alvarez ML, Cardineau GA.

Biotechnol Adv. 2010 Jan-Feb;28(1):184-96. doi: 10.1016/j.biotechadv.2009.11.006. Review.

PMID:
19931370
6.

Particle size and pathogenicity in the respiratory tract.

Thomas RJ.

Virulence. 2013 Nov 15;4(8):847-58. doi: 10.4161/viru.27172. Epub 2013 Nov 13. Review.

Supplemental Content

Support Center